RxDoctor Payments Data

Lindsay Rumberger-Rivera

Hospitalist · Knoxville, TNNPI 1235440843

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,136 of the $4,456 with a category attached, or 70.4%. It is spread thinly across 36 manufacturers, the largest accounting for just 21.4%. 2025 is the largest year on record at $2,693, more than ten times the $14 reported in 2019. Among hospitalist clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,456in general payments, 2019–2025

Across 159 payments — averaging $28.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$953
  • Astellas Pharma US Inc$532
  • Johnson & Johnson$352
  • Incyte Corporation$241
  • Regeneron Healthcare Solutions, Inc.$216
  • E.r. Squibb & Sons, L.L.C.$203
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$3,13670%
  • Education$72216%
  • Other$59813%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,456 in reported general payments places this provider in the 95th percentile of 349 hospitalist providers in Tennessee.

See all hospitalist providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
VerzenioAbemaciclib15$217,221
Ondansetron OdtOndansetron12$225
Lidocaine-PrilocaineLidocaine/Prilocaine16$198
Prochlorperazine Maleate12$174
Ondansetron Hcl11$122

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCVerzenio$86$217,22115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 349 hospitalist providers in Tennessee.

Other hospitalist in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →